The treatment of Parkinson's disease with deep brain stimulation: current issues

Neural Regeneration Research
Alexia-Sabine MoldovanL Wojtecki

Abstract

Deep brain stimulation has become a well-established symptomatic treatment for Parkinson's disease during the last 25 years. Besides improving motor symptoms and long-term motor complications, positive effects on patients' mobility, activities of daily living, emotional well-being and health-related quality of life have been recognized. Apart from that, numerous clinical trials analyzed effects on non-motor symptoms and side effects of deep brain stimulation. Several technical issues and stimulation paradigms have been and are still being developed to optimize the therapeutic effects, minimize the side effects and facilitate handling. This review summarizes current therapeutic issues, i.e., patient and target selection, surgical procedure and programming paradigms. In addition it focuses on neuropsychological effects and side effects of deep brain stimulation.

References

Jan 1, 1994·Stereotactic and Functional Neurosurgery·A L BenabidJ Perret
Oct 15, 1998·The New England Journal of Medicine·P LimousinA L Benabid
Sep 12, 2000·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·A M DamianoE D Means
Mar 2, 2002·Brain : a Journal of Neurology·M L WelterY Agid
May 23, 2002·Journal of Neurology, Neurosurgery, and Psychiatry·J L HouetoY Agid
Sep 24, 2004·Movement Disorders : Official Journal of the Movement Disorder Society·Stéphane ChapuisFranck Durif
Jul 1, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Jens VolkmannRajesh Pahwa
Jul 1, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Anthony E LangValerie Voon
Aug 8, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Galit Kleiner-FismanGünther Deuschl
Sep 1, 2006·The New England Journal of Medicine·Günther DeuschlUNKNOWN German Parkinson Study Group, Neurostimulation Section
Jan 11, 2007·Journal of Neurology, Neurosurgery, and Psychiatry·H M M SmedingB Schmand
Mar 24, 2007·Parkinsonism & Related Disorders·William G OndoKevin D Vuong
May 23, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Fabienne Ory-MagneOlivier Rascol
Jun 14, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Andrea A KühnPeter Brown
Sep 13, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Elina TripolitiPatricia Limousin
Sep 18, 2008·Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology·David KnobelAlexandre Berney
Dec 17, 2008·Lancet Neurology·Alim Louis BenabidPierre Pollak
Jan 8, 2009·JAMA : the Journal of the American Medical Association·Frances M WeaverUNKNOWN CSP 468 Study Group
Feb 25, 2009·Journal of Neurology, Neurosurgery, and Psychiatry·J M MannM S Okun
Jun 26, 2009·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Shen-Yang LimAndrew H Evans
Sep 15, 2009·AJNR. American Journal of Neuroradiology·D DormontE Bardinet
Sep 22, 2009·Journal of the Neurological Sciences·Stefani AlessandroAntonella Peppe
Mar 10, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Elena MoroAnthony E Lang
May 13, 2010·Stereotactic and Functional Neurosurgery·Mattias AströmKarin Wårdell
May 25, 2010·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Scott F LempkaCameron C McIntyre
Jun 4, 2010·The New England Journal of Medicine·Kenneth A FollettUNKNOWN CSP 468 Study Group
Jul 1, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Christine DanielsKarsten Witt
Aug 31, 2010·Brain : a Journal of Neurology·Alfonso FasanoAlberto Albanese
Sep 24, 2010·Stereotactic and Functional Neurosurgery·Frank SchneiderAlfons Schnitzler
Oct 13, 2010·Archives of Neurology·Jeff M BronsteinMahlon R DeLong
Aug 10, 2011·Archives of Neurology·Anna CastriotoElena Moro
Jun 23, 2012·Neurology·Frances M WeaverUNKNOWN CSP 468 Study Group

❮ Previous
Next ❯

Citations

Sep 11, 2016·Neurochemical Research·Gunnar F KwakyeMichael Aschner
Nov 23, 2017·Neuromodulation : Journal of the International Neuromodulation Society·Carlos TrenadoLars Wojtecki
Feb 13, 2018·Computational Intelligence and Neuroscience·Ángeles TepperJuan Guerrero Martínez
Dec 3, 2016·Clinical Science·Mariela MitreMoses V Chao
May 7, 2019·Frontiers in Neuroscience·Lisa-Maria Schönfeld, Lars Wojtecki
Jan 5, 2017·Parkinson's Disease·Valéria de Carvalho FagundesMirna Wetters Portuguez
Jun 5, 2021·Postgraduate Medicine·Robert A HauserCynthia L Comella
Jul 28, 2021·Expert Opinion on Drug Delivery·Michael M LippPeter A LeWitt
Aug 10, 2021·Journal of Parkinson's Disease·Andrea M LoftusSarah J Egan

❮ Previous
Next ❯

Software Mentioned

CUSTOM

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.